AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+38.79%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.14B
AUM Growth
+$4.14B
Cap. Flow
+$72.5M
Cap. Flow %
1.75%
Top 10 Hldgs %
92.37%
Holding
74
New
9
Increased
9
Reduced
10
Closed
3

Sector Composition

1 Consumer Staples 51.92%
2 Healthcare 25.71%
3 Consumer Discretionary 17.85%
4 Financials 1.87%
5 Technology 0.56%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
QCOM icon
26
Qualcomm
QCOM
$170B
$8.22M 0.15%
+164,500
New +$8.22M
CCXI
27
DELISTED
ChemoCentryx, Inc.
CCXI
$7.29M 0.14%
900,000
CLLS
28
Cellectis
CLLS
$260M
$6.52M 0.12%
210,000
+85,000
+68% +$2.64M
RXDX
29
DELISTED
Ignyta, Inc.
RXDX
$6.37M 0.12%
475,000
MCRB icon
30
Seres Therapeutics
MCRB
$162M
$6.14M 0.12%
175,000
-25,000
-13% -$877K
CLDX icon
31
Celldex Therapeutics
CLDX
$1.57B
$5.88M 0.11%
375,000
LCTX icon
32
Lineage Cell Therapeutics
LCTX
$281M
$5.26M 0.1%
1,282,050
DAL icon
33
Delta Air Lines
DAL
$40B
$5.07M 0.1%
+100,000
New +$5.07M
JMEI
34
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$4.53M 0.09%
500,000
IBRX icon
35
ImmunityBio
IBRX
$2.24B
$3.9M 0.07%
225,000
+50,000
+29% +$866K
RGNX icon
36
Regenxbio
RGNX
$498M
$2.66M 0.05%
160,000
+42,600
+36% +$707K
IRWD icon
37
Ironwood Pharmaceuticals
IRWD
$201M
$2.51M 0.05%
216,879
AGEN
38
Agenus
AGEN
$136M
$2.5M 0.05%
550,000
DMTX
39
DELISTED
Dimension Therapeutics, Inc
DMTX
$1.97M 0.04%
+175,000
New +$1.97M
PARN
40
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$1.94M 0.04%
500,000
SPNC
41
DELISTED
Spectranetics Corp
SPNC
$1.51M 0.03%
100,000
CERE
42
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$338K 0.01%
1,024,020
CLCD
43
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$47K ﹤0.01%
5,575
TWX
44
DELISTED
Time Warner Inc
TWX
0
AAPL icon
45
Apple
AAPL
$3.54T
0
AMZN icon
46
Amazon
AMZN
$2.41T
0
AXP icon
47
American Express
AXP
$225B
0
BAC icon
48
Bank of America
BAC
$371B
-1,000,000
Closed -$15.6M
BIIB icon
49
Biogen
BIIB
$20.8B
0
BMY icon
50
Bristol-Myers Squibb
BMY
$96.7B
0